Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primaryliver tumors with β-catenin mutations

被引:81
作者
Cavard, C
Terris, B
Grimber, G
Christa, L
Audard, V
Bussiere, BR
Simon, MT
Renard, CA
Buendia, MA
Perret, C
机构
[1] Univ Paris 05, INSERM, U567, CNRS,UMR 8104,Inst Cochin,Dept GDPM, F-75014 Paris, France
[2] Univ Paris 05, Hop Cochin, Serv Anat Pathol, F-75014 Paris, France
[3] Univ Paris 05, Inst Necker Pasteur, INSERM, U370, F-75014 Paris, France
[4] Inst Pasteur, INSERM, U579, Unite Oncogenese & Virol Mol, F-75724 Paris, France
关键词
beta-catenin; REG1A; REG3A; hepatocellular; carcinoma; hepatoblastoma; Wnt signaling;
D O I
10.1038/sj.onc.1208860
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Wnt/beta-catenin signaling pathways activated in many human hepatocellular carcinomas (HCC). We tried to identify the genes involved in carcinogenesis and progression of HCC with beta-catenin mutations. We used PCR-based subtractive hybridization to compare gene expression between malignant and benign components of a human HCC occurring in pre-existing adenoma activated for beta-catenin. Two of the genes identified belong to the Regenerating gene (REG) family. They encode the Regenerating islet-derived 3 alpha (REG3A/HIP/PAP/ REG-III) and 1 alpha (REG1A) proteins, both involved in liver and pancreatic regeneration and proliferation. Using siRNA directed against beta-catenin, we demonstrated that REG3A is a target of beta-catenin signaling in Huh7 hepatoma cells. The upregulation of REG3A and REG1A expression is significantly correlated to the beta-catenin status in 42 HCC and 28 hepatoblastomas characterized for their b-catenin status. Thus, we report strong evidence that both genes are downstream targets of the Wnt pathway during liver tumorigenesis.
引用
收藏
页码:599 / 608
页数:10
相关论文
共 48 条
[1]   Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine [J].
Andreu, P ;
Colnot, S ;
Godard, C ;
Gad, S ;
Chafey, P ;
Niwa-Kawakita, M ;
Laurent-Puig, P ;
Kahn, A ;
Robine, S ;
Perret, C ;
Romagnolo, B .
DEVELOPMENT, 2005, 132 (06) :1443-1451
[2]   Expression of REG protein during cell growth and differentiation of two human colon carcinoma cell lines [J].
Bernard-Perrone, FR ;
Renaud, WP ;
Guy-Crotte, OM ;
Bernard, P ;
Figarella, CG ;
Okamoto, H ;
Balas, DC ;
Senegas-Balas, FO .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1999, 47 (07) :863-870
[3]   Genetic alterations in hepatocellular adenomas [J].
Bioulac-Sage, P ;
Laurent-Puig, P ;
Balabaud, C ;
Zucman-Rossi, J .
HEPATOLOGY, 2003, 37 (02) :480-480
[4]   Bi-allelic inactivation of TCF1 in hepatic adenomas [J].
Bluteau, O ;
Jeannot, E ;
Bioulac-Sage, P ;
Marqués, JM ;
Blanc, JF ;
Bui, H ;
Beaudoin, JC ;
Franco, D ;
Balabaud, C ;
Laurent-Puig, P ;
Zucman-Rossi, J .
NATURE GENETICS, 2002, 32 (02) :312-315
[5]   Focus on hepatocellular carcinoma [J].
Bruix, J ;
Boix, L ;
Sala, M ;
Llovet, JM .
CANCER CELL, 2004, 5 (03) :215-219
[6]  
Buckhaults P, 2001, CANCER RES, V61, P6996
[7]   Genetic alterations in hepatoblastoma and hepatocellular carcinoma: Common and distinctive aspects [J].
Buendia, MA .
MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (05) :530-535
[8]  
Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185
[9]   New targets of β-catenin signaling in the liver are involved in the glutamine metabolism [J].
Cadoret, A ;
Ovejero, C ;
Terris, B ;
Souil, E ;
Lévy, L ;
Lamers, WH ;
Kitajewski, J ;
Kahn, A ;
Perret, C .
ONCOGENE, 2002, 21 (54) :8293-8301
[10]   P53 gene and wnt signaling in benign Neoplasms:: β-Catenin mutations in hepatic adenoma but not in focal nodular hyperplasia [J].
Chen, YW ;
Jeng, YM ;
Yeh, SH ;
Chen, PJ .
HEPATOLOGY, 2002, 36 (04) :927-935